2020 Annual Meeting | C175 - Paroxysmal Movement Disorders

Date Wednesday 04/29/20

Time 07:00 AM - 09:00 AM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Ryan R. Walsh, MD, PhD, FAAN

Topic(s) Movement Disorders

Learning Objectives Participants should be able to identify/classify the different types of paroxysmal movement disorders and be able to order relevant investigations, whether they be imaging, biochemical/serologic, or genetic, to arrive at the diagnosis. Participants should also be able to consider therapeutic options for the different forms of paroxysmal movement disorders.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist

Teaching Styles Case-based, Didactic, Audience Participation

Event Timeline
07:00 AM - 07:40 AM	Speaker	Classification and Genetics of Paroxysmal Movement Disorders Joseph Jankovic, MD, FAAN
07:40 AM - 08:20 AM	Speaker	Phenomenology of Paroxysmal Movement Disorders Khashayar Dashtipour, MD, PhD
08:20 AM - 09:00 AM	Speaker	Pathophysiology and Treatment of Paroxysmal Movement Disorders Bettina Balint, MD

Faculty Disclosures
Joseph Jankovic, MD, FAAN	Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance, Allergan. The institution of Dr. Jankovic has received research support from Baylor College of Medicine. Dr. Jankovic has received research support from Abbvie. The institution of Dr. Jankovic has received research support from Abbvie.
Khashayar Dashtipour, MD, PhD	Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine . Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for teva. Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for abbvie. Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for acadia. Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for kyowa kirin . Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for amneal . Dr. Dashtipour has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for neurocrine . Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for teva. Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for abbvie. Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for kyowa Kirin . Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for ipsen. Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for amneal . Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for acorda. The institution of Dr. Dashtipour has received research support from Abbvie. The institution of Dr. Dashtipour has received research support from ipsen. The institution of Dr. Dashtipour has received research support from amneal.
Ryan R. Walsh, MD, PhD, FAAN	Dr. Walsh has received personal compensation for serving as an employee of Praxis Precision Medicines. Dr. Walsh has stock in Praxis Precision Medicines.
Bettina Balint, MD	Dr. Balint has nothing to disclose.

��ɫ��

��ɫ��